Maike Nickelsen

Suggest Changes
Learn More
BACKGROUND High-dose therapy (HDT) followed by transplantation of autologous haemopoietic stem cells is frequently done as part of first-line therapy in young patients with high-risk aggressive(More)
BACKGROUND T-cell lymphomas (T-NHL) generally carry a poor prognosis. High-dose therapy (HDT) and autologous stem cell transplantation (ASCT) are increasingly used to treat younger patients. DESIGN(More)
8002 Background: Studies comparing HDT with conventional first-line therapy for younger patients (pts.) with aggressive B-cell lymphoma gave conflicting results. None of these studies combined(More)
Chronic myeloid leukaemia (CML) is believed to represent a stem cell disorder involving all three cell lineages. The typical chromosomal aberration, the Philadelphia chromosome, is the translocation(More)